Menon Sandeep

Menon Sandeep is listed in filings as Chief R&D Officer at BioCryst Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Apr 7, 2026, including 2 public disclosures. Recent filings connect the profile to BioCryst Pharmaceuticals Inc (BCRX). The current snapshot covers public activity from Apr 7, 2026. Reported amounts are shown as $4.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.